148 related articles for article (PubMed ID: 2464961)
1. NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection.
Fauci AS; Gallo RC; Koenig S; Salk J; Purcell RH
Ann Intern Med; 1989 Mar; 110(5):373-85. PubMed ID: 2464961
[TBL] [Abstract][Full Text] [Related]
2. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.
Nara PL; Robey WG; Arthur LO; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC; Fischinger PJ
J Virol; 1987 Oct; 61(10):3173-80. PubMed ID: 2442411
[TBL] [Abstract][Full Text] [Related]
3. The development of an AIDS vaccine: progress and promise.
Fauci AS; Fischinger PJ
Public Health Rep; 1988; 103(3):230-6. PubMed ID: 3131812
[TBL] [Abstract][Full Text] [Related]
4. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
5. Progress in HIV vaccine research.
van der Ryst E
Oral Dis; 2002; 8 Suppl 2():21-6. PubMed ID: 12164654
[TBL] [Abstract][Full Text] [Related]
6. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
7. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
[TBL] [Abstract][Full Text] [Related]
8. Challenges in the search for an HIV vaccine.
Lemckert AA; Goudsmit J; Barouch DH
Eur J Epidemiol; 2004; 19(6):513-6. PubMed ID: 15330122
[TBL] [Abstract][Full Text] [Related]
9. [AIDS vaccines: an enigma in vaccine development].
Dorner F; Barrett N
Wien Klin Wochenschr; 1990 Jan; 102(2):51-8. PubMed ID: 1689919
[TBL] [Abstract][Full Text] [Related]
10. Development of artificial vaccines against HIV using defined epitopes.
Berzofsky JA
FASEB J; 1991 Jul; 5(10):2412-8. PubMed ID: 1712327
[TBL] [Abstract][Full Text] [Related]
11. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.
Johnson RP; Trocha A; Buchanan TM; Walker BD
J Exp Med; 1992 Apr; 175(4):961-71. PubMed ID: 1372650
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocytes against HIV.
Walker BD; Plata F
AIDS; 1990 Mar; 4(3):177-84. PubMed ID: 1693514
[TBL] [Abstract][Full Text] [Related]
13. [Development of HIV vaccines].
Shibata R
Nihon Rinsho; 2002 Apr; 60(4):790-7. PubMed ID: 11968790
[TBL] [Abstract][Full Text] [Related]
14. Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees.
Gibbs CJ; Peters R; Gravell M; Johnson BK; Jensen FC; Carlo DJ; Salk J
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3348-52. PubMed ID: 2014254
[TBL] [Abstract][Full Text] [Related]
15. Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection.
Koup RA; Pikora CA; Mazzara G; Panicali D; Sullivan JL
Viral Immunol; 1991; 4(4):215-23. PubMed ID: 1726398
[TBL] [Abstract][Full Text] [Related]
16. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.
Krohn K; Robey WG; Putney S; Arthur L; Nara P; Fischinger P; Gallo RC; Wong-Staal F; Ranki A
Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4994-8. PubMed ID: 2440037
[TBL] [Abstract][Full Text] [Related]
17. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
[TBL] [Abstract][Full Text] [Related]
18. Modern vaccines. Human immunodeficiency virus and AIDS: challenges and progress.
Schild GC; Minor PD
Lancet; 1990 May; 335(8697):1081-4. PubMed ID: 1970381
[No Abstract] [Full Text] [Related]
19. Development and testing of AIDS vaccines.
Koff WC; Hoth DF
Science; 1988 Jul; 241(4864):426-32. PubMed ID: 3293212
[TBL] [Abstract][Full Text] [Related]
20. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.
Hu SL; Fultz PN; McClure HM; Eichberg JW; Thomas EK; Zarling J; Singhal MC; Kosowski SG; Swenson RB; Anderson DC
Nature; 1987 Aug 20-26; 328(6132):721-3. PubMed ID: 3475581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
